MEND

MEND

Private
New York City, New YorkCybersecurityhttps://www.mend.me

Last Round

Series A

Jun 6, 2023

Total Funding Raised

$15M

Company Overview

Mend is a healthcare company that develops clinical nutritional products aimed at supporting healing and improving quality of life through innovative medical food interventions.

Sector

Cybersecurity

Verticals

Application Security, Vulnerability Management, DevOps & Containers, Cloud Security

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

application security platformAppSec platformsoftware composition analysisSCAstatic application security testingSASTautomated remediationopen source securitycontainer securityDevSecOps platformshift left securityautomated dependency updatesdependency scanningcode scanningvulnerability managementsoftware bill of materialsSBOMAI application security

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MEND Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MEND Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 6, 2023
SeedDec 27, 2020
SeedJul 27, 2016

Key People

Founding team and executive leadership

Eziah Syed

Founder And CEO

Founding Team

Adam Tichelaar

Chief Technology Officer

Executive Team

Chris Gusty

COO

Executive Team

MEND Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 5, 2025

    Launched Asia-Pacific Clinical Advisory Board with leading surgeons.

  • Jul 27, 2016

    Raised a Seed round with the Institute for Commercialization of Florida Technology.

MEND Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MEND Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MEND's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range47
Year Founded2014
Last FundingJun 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.